Insight

Varadha Balaji Venkadakrishnan: Lineage-specific activity of EZH2 in advanced Prostate Cancer

Photo from Varadha Balaji Venkadakrishnan/X

Aug 12, 2024, 22:05

Varadha Balaji Venkadakrishnan: Lineage-specific activity of EZH2 in advanced Prostate Cancer

Varadha Balaji Venkadakrishnan, Postdoctoral Researcher at Dana-Farber Cancer Institute, shared on X about a recent paper titled “Lineage-specific canonical and non-canonical activity of EZH2 in advanced prostate cancer subtypes” published in Nature Communications.

Authors: Varadha Balaji Venkadakrishnan et al.

specific activity

“Check out our paper on lineage-specific activity of EZH2 in advanced Prostate Cancer subtypes published in Nature Communications.

Thank you Misha Beltran for strong support!”

specific activity

Source: Varadha Balaji Venkadakrishnan/X

Adam Presser cancer Dana-Farber Cancer Institute David Rickman EZH2 Himisha Beltran Misha Beltran Myles Brown National Cancer Center Nature Communications OncoDaily Oncology PCF Science prostate cancer Richa Singh Varadha Balaji Venkadakrishnan

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer